SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NOVARTIS INDIA

BSE: 500672 28 Jun 2025
Healthcare
₹ 1019
Novartis India Limited. specializes in Pharmaceuticals within the Healthcare sector.

NOVARTIS INDIA - Share Price & Details

Market Cap
₹2,506
High /Low
1,248 / 745.0
Stock P/E
24.8
Book Value
₹318.0
Dividend Yield
2.46
ROCE
17.0
ROE
₹13.2
Face Value
5.0
PEG Ratio
0.42
EVEBITDA
₹14.0
Debt
5.06
CMP / FCF
32.2
Debt to equity
₹0.01
NP Ann
101
High price all time
1,248
Piotroski score
₹8.0
Graham Number
541.0
No. Eq. Shares
2.47
Net CF
₹7.11
Net profit
101
Price to book value
3.19
Interest Coverage
₹170.0
Low price all time
221.0
Industry PE
32.0
Reserves
₹773
Free Cash Flow
₹74.9

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
NOVARTIS INDIA LTD.NANANANA2,50624.8
SOLARA ACTIVE PHARMA SCIENCES2789.6-48.82730.1-1.6523634,376
Krsnaa Diagnostics Limited1904.64206.781860.766.28228429.4

Peer Comparison Chart


About NOVARTIS INDIA

Novartis India Limited., with Security Code 500672, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

How has been the historical performance of the Novartis India?

(07 Jun 2025)
Novartis India has experienced fluctuating financial performance, with net sales declining from Rs 490.68 crore in March 2019 to Rs 356.27...
Read more →

Are You Ready For Hefty Rs 25 Dividend By Pharma Stock? Record Date In July; Here’s How to Trade

(12 May 2025)
A subsidiary of the multinational pharmaceutical corporation Novartis, which has had a major presence in India since 1947, is Novartis India...
Read more →

Novartis India Standalone March 2025 Net Sales at Rs 83.88 crore, up 3.34% Y-o-Y

(12 May 2025)
Net Sales at Rs 83.88 crore in March 2025 up 3.34% from Rs. 81.17 crore in March 2024. Story continues below Advertisement.
Read more →

Q4 Results Highlights: Novartis India profit doubles; Thermax misses estimates

(10 May 2025)
Q4 Results Highlights: The fourth quarter earnings season is underway and as many as 10 important names like Dr Reddy's Laboratories,...
Read more →

AI-Powered Health Care Will Transform Drug Discovery, Says Novartis India MD

(03 May 2025)
India's transformation from "pharmacy of the world" to fostering a robust R&D ecosystem is crucial for the country to be a global leader in...
Read more →

Industry leaders suggest how 'Make in India' can succeed

(19 Apr 2025)
On October 13, eight top corporate executives got together at the ITC Grand Central in Mumbai to ruminate and reflect on the topic "Make in India: Ambitious...
Read more →